Literature DB >> 15231425

Levels of evidence: universal newborn hearing screening (UNHS) and early hearing detection and intervention systems (EHDI).

Christine Yoshinaga-Itano1.   

Abstract

UNLABELLED: Levels of evidence differ according to the audience addressed. Implementation of universal newborn hearing screening requires responses to a complex myriad of diverse groups: the general public, families with children who are deaf or hard of hearing, the deaf and hard of hearing communities, hospital administrators, physicians (pediatricians, general practitioners, ear nose and throat physicians, geneticists), managed care, Medicaid, insurance agencies, and politicians. The level of evidence required by medical/health agencies and task forces may differ from the levels of evidence available in education and intervention. Issues related to the low incidence of the disability, the lack of a normal distribution within the disability study, the obstacles to random assignment to treatment, and designs that include a control group with "no treatment" have implications legally and ethically for the professional providing services to families and children who are deaf or hard of hearing. This session will discuss issues related to "convenience samples," number of subjects included in research studies, and the population required to obtain a large enough sample of children with low-incidence disabilities. The level of evidence required to demonstrate sensitive periods of development, which are a critical element for justification of implementing a universal newborn hearing screening includes both behavioral and neurological information. Sensitive periods may have different duration for different aspects of development, such as social-emotional development, auditory and speech development, or language development. Further complicating the question of sensitive periods of development are the distinct possibility that different sensitive periods exist for development of age-level vocabulary, for establishing English phonology, or for mastering English syntax. Research outcomes provide evidence that age of identification of hearing loss is reduced, that age of intervention initiation is lowered, and that the outcomes of intervention are better because of the establishment of a screening program. Most professionals in communication disorders believe that screening is not the actual cause of better developmental outcomes but that the age when children begin to have access to language and communication and the characteristics of the intervention are the primary cause of better outcomes. Screening is the avenue through which access to quality intervention is made available. The research still remains at an infant level of development such that there is very little evidence for the efficacy of specific characteristics of the intervention provided. LEARNING OUTCOMES: (1) The learner will be able to identify the obstacles in conducting research on the effectiveness of intervention of children identified through universal newborn hearing screening programs. (2) The learner will be able to identify the type of research on developmental outcomes of children with early-identified hearing loss.

Entities:  

Mesh:

Year:  2004        PMID: 15231425     DOI: 10.1016/j.jcomdis.2004.04.008

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  37 in total

1.  Interdisciplinary approach to design, performance, and quality management in a multicenter newborn hearing screening project. Discussion of the results of newborn hearing screening in Hamburg (part II).

Authors:  Anna-Katharina Rohlfs; Thomas Wiesner; Holger Drews; Frank Müller; Achim Breitfuss; Regina Schiller; Markus Hess
Journal:  Eur J Pediatr       Date:  2010-06-11       Impact factor: 3.183

2.  The potential risk factors and the identification of hearing loss in infants.

Authors:  Ashok Kumar Biswas; S C Goswami; Dilip Kumar Baruah; Rajesh Tripathy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-09-04

3.  Midwives' knowledge, attitudes, and practices related to newborn hearing screening.

Authors:  Martha Hoffman Goedert; Mary Pat Moeller; Karl R White
Journal:  J Midwifery Womens Health       Date:  2011 Mar-Apr       Impact factor: 2.388

4.  A Technology-Assisted Language Intervention for Children Who Are Deaf or Hard of Hearing: A Randomized Clinical Trial.

Authors:  Jareen Meinzen-Derr; Rose Sheldon; Mekibib Altaye; Laura Lane; Lindsay Mays; Susan Wiley
Journal:  Pediatrics       Date:  2021-01-15       Impact factor: 7.124

5.  Early hearing detection and intervention in Canada.

Authors:  Puneeta Khurana; Sharon L Cushing; Pranesh K Chakraborty; Jessica K Dunn; Vicky A Papaioannou; Rosemary G Moodie; Blake C Papsin; Peter D Wong
Journal:  Paediatr Child Health       Date:  2020-07-08       Impact factor: 2.253

Review 6.  Disparities in access to pediatric hearing health care.

Authors:  Matthew L Bush; Michael R Kaufman; Beth N McNulty
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2017-10       Impact factor: 2.064

Review 7.  The role of the health system in the prevention of hearing loss among children in Sub-Saharan Africa.

Authors:  Fayrouz Mohammed Abdalla; Mayeh Abu Omar
Journal:  Sudan J Paediatr       Date:  2011

8.  Age at Intervention for Permanent Hearing Loss and 5-Year Language Outcomes.

Authors:  Teresa Y C Ching; Harvey Dillon; Laura Button; Mark Seeto; Patricia Van Buynder; Vivienne Marnane; Linda Cupples; Greg Leigh
Journal:  Pediatrics       Date:  2017-08-03       Impact factor: 7.124

Review 9.  Ethical and social implications of genetic testing for communication disorders.

Authors:  Kathleen S Arnos
Journal:  J Commun Disord       Date:  2008-03-25       Impact factor: 2.288

10.  A Qualitative Study on Knowledge and Attitude towards Risk Factors, Early Identification and Intervention of Infant Hearing Loss among Puerperal Mothers- A Short Survey.

Authors:  Ravi Dudda; Hanumanth Prasad Muniyappa; Sahana Puttaraju; M S Lakshmi
Journal:  J Clin Diagn Res       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.